Mice heterozygous for CREB binding protein are hypersensitive to γ-radiation and invariably develop myelodysplastic/myeloproliferative neoplasm

作者: Stephanie N Zimmer , Madeleine E Lemieux , Bijal P Karia , Claudia Day , Ting Zhou

DOI: 10.1016/J.EXPHEM.2011.12.004

关键词: XRCC1Myelodysplastic syndromesGenome instabilityBiologyMyeloid leukemiaCREB-binding proteinMyeloproliferative DisordersMyelodysplastic/Myeloproliferative NeoplasmMyeloproliferative neoplasmCancer researchImmunology

摘要: Myelodysplastic syndrome is a complex family of preleukemic diseases in which hematopoietic stem cell defects lead to abnormal differentiation one or more blood lineages. Disease progression associated with increasing genomic instability and large proportion patients go on develop acute myeloid leukemia. Primarily disease the elderly, it can also after chemotherapy. We have previously reported that CREB binding protein ( Crebbp) heterozygous mice an increased incidence hematological malignancies, others shown CREBBP genes altered by chromosomal translocations found suffering from therapy-related myelodysplastic syndrome. This led us investigate whether tumor development Crebbp +/− preceded phase we could uncover molecular mechanisms might contribute its development. report here invariably myelodysplastic/myeloproliferative neoplasm within 9 12 months age. They are hypersensitive ionizing radiation show marked decrease poly(ADP-ribose) polymerase-1 activity irradiation. In addition, levels XRCC1 APEX1, key components base excision repair machinery, reduced unirradiated cells upon targeted knockdown levels. Our results provide validation novel mouse model and, importantly, point defective DNA damage as contributing factor pathogenesis this currently incurable disease.

参考文章(48)
Blanche P. Alter, Neelam Giri, Sharon A. Savage, June A. Peters, Jennifer T. Loud, Lisa Leathwood, Ann G. Carr, Mark H. Greene, Philip S. Rosenberg, Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. British Journal of Haematology. ,vol. 150, pp. 179- 188 ,(2010) , 10.1111/J.1365-2141.2010.08212.X
Wei Gu, Xiao-Lu Shi, Robert G. Roeder, Synergistic activation of transcription by CBP and p53 Nature. ,vol. 387, pp. 819- 823 ,(1997) , 10.1038/42972
Elias Campo, N Lee Harris, Elaine S Jaffe, Stefano A Pileri, Harald Stein, Jurgen Thiele, James W Vardiman, None, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues ,(2017)
Yoshihito IWAHARA, Kazuyoshi ISHII, Seiji WATANABE, Hirokuni TAGUCHI, Hiroshi HARA, Isao MIYOSHI, Bloom's Syndrome Complicated by Myelodysplastic Syndrome and Multiple Neoplasia. Internal Medicine. ,vol. 32, pp. 399- 402 ,(1993) , 10.2169/INTERNALMEDICINE.32.399
Annahita Sallmyr, Jinshui Fan, Kamal Datta, Kyu-Tae Kim, Dan Grosu, Paul Shapiro, Donald Small, Feyruz Rassool, Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML. Blood. ,vol. 111, pp. 3173- 3182 ,(2008) , 10.1182/BLOOD-2007-05-092510
Jean-François Rual, Kavitha Venkatesan, Tong Hao, Tomoko Hirozane-Kishikawa, Amélie Dricot, Ning Li, Gabriel F. Berriz, Francis D. Gibbons, Matija Dreze, Nono Ayivi-Guedehoussou, Niels Klitgord, Christophe Simon, Mike Boxem, Stuart Milstein, Jennifer Rosenberg, Debra S. Goldberg, Lan V. Zhang, Sharyl L. Wong, Giovanni Franklin, Siming Li, Joanna S. Albala, Janghoo Lim, Carlene Fraughton, Estelle Llamosas, Sebiha Cevik, Camille Bex, Philippe Lamesch, Robert S. Sikorski, Jean Vandenhaute, Huda Y. Zoghbi, Alex Smolyar, Stephanie Bosak, Reynaldo Sequerra, Lynn Doucette-Stamm, Michael E. Cusick, David E. Hill, Frederick P. Roth, Marc Vidal, Towards a proteome-scale map of the human protein–protein interaction network Nature. ,vol. 437, pp. 1173- 1178 ,(2005) , 10.1038/NATURE04209
Elisa Pianigiani, Giovambattista De Aloe, Andrea Andreassi, Pietro Rubegni, Michele Fimiani, Rothmund-Thomson syndrome (Thomson-type) and myelodysplasia Pediatric Dermatology. ,vol. 18, pp. 422- 425 ,(2001) , 10.1046/J.1525-1470.2001.01971.X
Sarah H. Beachy, Peter D. Aplan, Mouse models of myelodysplastic syndromes. Hematology-oncology Clinics of North America. ,vol. 24, pp. 361- 375 ,(2010) , 10.1016/J.HOC.2010.02.002